BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21540899)

  • 1. Is refractory celiac disease more severe in old Europe?
    Malamut G; Cellier C
    Am J Gastroenterol; 2011 May; 106(5):929-32. PubMed ID: 21540899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory coeliac disease.
    Malamut G; Cellier C
    Curr Opin Oncol; 2013 Sep; 25(5):445-51. PubMed ID: 23942290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
    Malamut G; Afchain P; Verkarre V; Lecomte T; Amiot A; Damotte D; Bouhnik Y; Colombel JF; Delchier JC; Allez M; Cosnes J; Lavergne-Slove A; Meresse B; Trinquart L; Macintyre E; Radford-Weiss I; Hermine O; Brousse N; Cerf-Bensussan N; Cellier C
    Gastroenterology; 2009 Jan; 136(1):81-90. PubMed ID: 19014942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory Celiac Disease.
    Malamut G; Cellier C
    Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory celiac disease: epidemiology and clinical manifestations.
    Malamut G; Cellier C
    Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of refractory coeliac disease.
    Al-Toma A; Verbeek WH; Mulder CJ
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory celiac disease.
    Malamut G; Cellier C
    Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
    Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
    J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of complicated celiac disease.
    Al-toma A; Verbeek WH; Mulder CJ
    Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory celiac disease: from bench to bedside.
    Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
    Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsule endoscopy in refractory celiac disease.
    Daum S; Wahnschaffe U; Glasenapp R; Borchert M; Ullrich R; Zeitz M; Faiss S
    Endoscopy; 2007 May; 39(5):455-8. PubMed ID: 17516353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.
    Hrdlickova B; Mulder CJ; Malamut G; Meresse B; Platteel M; Kamatani Y; RicaƱo-Ponce I; van Wanrooij RLJ; Zorro MM; Jan Bonder M; Gutierrez-Achury J; Cellier C; Zhernakova A; Nijeboer P; Galan P; Withoff S; Lathrop M; Bouma G; Xavier RJ; Jabri B; Bensussan NC; Wijmenga C; Kumar V
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):828-837. PubMed ID: 29787419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and clinical spectrum of refractory celiac disease in a north american referral center.
    Roshan B; Leffler DA; Jamma S; Dennis M; Sheth S; Falchuk K; Najarian R; Goldsmith J; Tariq S; Schuppan D; Kelly CP
    Am J Gastroenterol; 2011 May; 106(5):923-8. PubMed ID: 21468013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine therapy in refractory celiac disease with aberrant T cells.
    Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in refractory coeliac disease: a review.
    Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
    Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
    Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system.
    Soderquist CR; Hsiao S; Mansukhani MM; Alobeid B; Green PH; Bhagat G
    Hematol Oncol; 2020 Aug; 38(3):399-405. PubMed ID: 32010998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.